US FDA Inspection In Store? Here Are Some Areas That May Be On Agency’s Radar

Risks like highly manual aseptic filling lines, poor root cause investigations and unwritten procedures were examined in Mumbai workshop.

Lachman_Officials
(L-R) Lachman executives David Lonza, Frances Zipp and Ron George

More from Manufacturing

More from Compliance